Close
Help
Need Help?



Most Highly Accessed Perspectives in Medicinal Chemistry Articles in October 2012

Posted Sun, Nov, 04,2012

These articles were the most highly accessed articles in Perspectives in Medicinal Chemistry in October 2012:The pKa Distribution of Drugs: Application to Drug Discovery (accessed 269 times)David T. ManallackChaperone Therapy for Neuronopathic Lysosomal Diseases: Competitive Inhibitors as Chemical Chaperones for Enhancement of Mutant Enzyme Activities (accessed 236 times)Yoshiyuki Suzuki, Seiichir...

Continue Reading →

Most Highly Accessed Substance Abuse: Research and Treatment Articles in October 2012

Posted Sun, Nov, 04,2012

These articles were the most highly accessed articles in Substance Abuse: Research and Treatment in October 2012:Epidemiologic and Molecular Pathophysiology of Chronic Opioid Dependence and the Place of Naltrexone Extended-Release Formulations in its Clinical Management (accessed 454 times)Albert Stuart ReeceCurrent and Emerging Directions in the Treatment of Eating Disorders (accessed 349 times)T...

Continue Reading →

Most Highly Accessed Translational Oncogenomics Articles in October 2012

Posted Sun, Nov, 04,2012

These articles were the most highly accessed articles in Translational Oncogenomics in October 2012:Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK) (accessed 263 times)Nancy Dos Santos, Golareh Habibi, Michelle Wang, Jennifer H. Law, Heather N. Andrews, Daniel Wei, Timothy Triche, Shoukat Dedhar and Sandra E. Dunn Implica...

Continue Reading →

Biomarkers in Cancer Added to ProQuest Biological Sciences

Posted Thu, Nov, 01,2012

We are pleased to announce the addition of Biomarkers in Cancer to Biological Sciences, a ProQuest database.ProQuest Biological Sciences Database includes full text, abstracts, and citations from over 4.5 million sources. Disciplines covered include biomedicine, biotechnology, zoology and ecology, agriculture, and veterinary science. The database is updated monthly and offers readers journal artic...

Continue Reading →

Signal Transduction Insights Indexing Partners

Posted Thu, Nov, 01,2012

Libertas works continually to increase online visibility for all our journals, and we are pleased to report that Signal Transduction Insights is now indexed by 12 external online databases and in 8 online directories and search engines.Indexing with so many external databases and directories means that articles published in Signal Transduction Insights are searchable in many places, meaning they a...

Continue Reading →

Journal of Cell Death Joins COPE

Posted Thu, Nov, 01,2012

Journal of Cell Death has formally joined the Committee on Publishing Ethics.COPE provides guidelines that are applied in situations such as where plagiarism allegations are made against a paper.  By becoming a COPE member there can be no doubt amongst authors of questionable papers that journals will apply commonly accepted industry-standard guidelines.  In more difficult cases Editors ...

Continue Reading →

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
My experience publishing in Human Parasitic Diseases was very positive.  I was very satisfied with the rapid and high-quality review process and the constructive feedback.  The comments from the reviewers allowed me to improve the paper significantly.  I highly recommend that other researchers publish their papers in Libertas Academia Journals.
Dr. Pedro Magalhães (Faculty of Medicine, Agostinho Neto University, Luanda, Angola)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results